Skip to content
NearWave logo — The NearWave Imager is a non-invasive imaging device for bre...

NearWave

The NearWave Imager is a non-invasive imaging device for breast cancer detection and monitoring.

Founded 2020 United States South Bend, United States 8 employees Seed Total: $500.00K Biotechnology, Health Care +1

General Information

Company Name NearWave
Founded Year 2020
Location United States South Bend, United States
Employees 8
Industries Biotechnology, Health Care, Information Technology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with NearWave. To contact NearWave, visit nearwave.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NearWave compare?

A PDF of NearWave and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NearWave soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NearWave

NearWave is a biotechnology startup based in United States, founded in 2020. The company's flagship product, the NearWave Imager, is a non-invasive imaging device designed for breast cancer detection and monitoring. Marketed with the slogan "The NearWave Imager is a non-invasive imaging device for breast cancer detection and monitoring," the device is a revolutionary handheld clinical near-infrared light imaging-based solution. NearWave aims to democratize point-of-care diagnostics and imaging in breast cancer, offering a significant advancement in healthcare technology. The startup recently secured Seed Round investment in the amount of undisclosed from IrishAngels in 15 June 2022. With its innovative approach to healthcare and technology, NearWave is poised to make a significant impact in the fields of biotechnology, healthcare, and information technology. This recent investment signifies a vote of confidence in the company's potential to disrupt the status quo in breast cancer diagnostics and monitoring.

Business keywords: breast cancer detection, non-invasive imaging, near-infrared light imaging, point-of-care diagnostics, clinical imaging device, real-time imaging data, quantitative imaging

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
IrishAngels
15 Jun 2022
Pre Seed Round $500.00K 1
Y Combinator
10 Mar 2022

NearWave Alternatives & Competitors

View All Alternatives
NearWave vs

The makers of IzoView Breast CT, a dedicated imaging platform for more accurate detection and diagno...

Post-IPO Equity
8 employees
Health Care, Information Technology
NearWave vs
NovaScan
NovaScan United States

Easy to use ex vivo and in vivo cancer detection that provides instantaneous, highly accurate result...

Convertible Note
16 employees
Biotechnology, Health Care
NearWave vs

Pioneering non-invasive skin cancer detection with advanced infrared laser and AI technology

Venture round
11-50 employees
Biotechnology, Health Care

FAQ About NearWave

The NearWave Imager is a non-invasive imaging device for breast cancer detection and monitoring.
NearWave was founded in 2020.
NearWave is headquartered in South Bend, United States.
NearWave operates in Biotechnology, Health Care and Information Technology. Its work centres on breast cancer detection, non-invasive imaging, near-infrared light imaging and point-of-care diagnostics.
NearWave has approximately 8 employees.
NearWave has completed 2 funding rounds, raising a total of $500.00K. The latest funding stage is Seed.
Top alternatives and competitors to NearWave include Izotropic Corp. (CSE: IZO | OTCQB: IZOZF), NovaScan, Magnosco, Beacon Biomedical, Bioptigen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NearWave and Izotropic Corp. (CSE: IZO | OTCQB: IZOZF) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NearWave, https://bouncewatch.com/company/nearwave, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout